Novo Nordisk A/S et al v. Caraco Pharmaceutical Laboratories, Limited

Filing 474

ORDER re 473 Exhibit filed by Novo Nordisk A/S, Novo Nordisk, Incorporated. Signed by District Judge Avern Cohn. (JOwe)

Novo Nordisk A/S et al v. Caraco Pharmaceutical Laboratories, Limited

Doc. 474

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION NOVO NORDISK A/S, et al., Plaintiffs, -vsCARACO PHARMACEUTICAL LABORATORIES, LTD., et al., Defendants. ________________________________/ ORDER Novo Nordisk's objections to DX 394 and DX 477A (Doc. 473) are OVERRULED for the reasons stated on the record on July 20, 2010. Particularly, DX 394 is a demonstrative exhibit displaying in graphic form the results of the testing described in DX 201, DX 61 (which is a duplicate of PX 44) and DX 246, publications which were identified in the testimony. Particularly, DX 477A is a graphic display of diabetic drugs identified in the testimony. SO ORDERED. Case No. 05-40188 Hon: AVERN COHN

Dated: July 22, 2010

S/Avern Cohn AVERN COHN UNITED STATES DISTRICT JUDGE

I hereby certify that a copy of the foregoing document was mailed to the attorneys of record on this date, July 22, 2010, by electronic and/or ordinary mail. S/Julie Owens Case Manager, [phone]

Dockets.Justia.com